PDT Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

PDT Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$602K	Sell	1,353 -6,763	-83%	-$3.01M	0.03%	504
2025 Q1	$3.93M	Sell	8,116 -1,687	-17%	-$818K	0.28%	108
2024 Q4	$3.95M	Buy	+9,803	New	+$3.95M	0.35%	76
2024 Q3	–	Sell	-1,010	Closed	-$473K	–	831
2024 Q2	$473K	Hold	1,010	–	–	0.04%	473
2024 Q1	$422K	Sell	1,010 -4,200	-81%	-$1.76M	0.04%	480
2023 Q4	$2.12M	Sell	5,210 -2,012	-28%	-$819K	0.23%	136
2023 Q3	$2.51M	Buy	7,222 +4,912	+213%	+$1.71M	0.32%	96
2023 Q2	$813K	Sell	2,310 -800	-26%	-$282K	0.11%	298
2023 Q1	$980K	Buy	+3,110	New	+$980K	0.13%	266
2022 Q3	–	Sell	-27,003	Closed	-$7.61M	–	1110
2022 Q2	$7.61M	Buy	27,003 +2,203	+9%	+$621K	0.67%	2
2022 Q1	$6.47M	Buy	24,800 +292	+1%	+$76.2K	0.56%	14
2021 Q4	$5.38M	Sell	24,508 -2,093	-8%	-$460K	0.41%	36
2021 Q3	$4.83M	Buy	26,601 +3,788	+17%	+$687K	0.35%	81
2021 Q2	$4.6M	Buy	22,813 +21,412	+1,528%	+$4.32M	0.3%	114
2021 Q1	$301K	Sell	1,401 -22,625	-94%	-$4.86M	0.02%	618
2020 Q4	$5.68M	Sell	24,026 -4,174	-15%	-$986K	0.38%	76
2020 Q3	$7.67M	Sell	28,200 -300	-1%	-$81.6K	0.51%	46
2020 Q2	$8.27M	Buy	+28,500	New	+$8.27M	0.56%	33
2017 Q2	–	Sell	-72,300	Closed	-$7.91M	–	580
2017 Q1	$7.91M	Sell	72,300 -3,900	-5%	-$426K	0.41%	85
2016 Q4	$5.61M	Buy	76,200 +16,280	+27%	+$1.2M	0.37%	113
2016 Q3	$5.23M	Hold	59,920	–	–	0.31%	135
2016 Q2	$5.15M	Hold	59,920	–	–	0.41%	119
2016 Q1	$4.76M	Buy	59,920 +31,400	+110%	+$2.5M	0.3%	148
2015 Q4	$3.59M	Sell	28,520 -17,165	-38%	-$2.16M	0.49%	71
2015 Q3	$4.76M	Buy	45,685 +2,076	+5%	+$216K	0.11%	234
2015 Q2	$5.39M	Buy	+43,609	New	+$5.39M	0.14%	181
2013 Q4	–	Sell	-61,977	Closed	-$4.7M	–	1178
2013 Q3	$4.7M	Buy	61,977 +43,972	+244%	+$3.33M	0.13%	200
2013 Q2	$1.44M	Buy	+18,005	New	+$1.44M	0.04%	681